![Rachel Diamant](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Rachel Diamant has held the title of Chief Intellectual Property Officer at Emendo Biotherapeutics, Inc. since 2015.
She is also the founder of Emendo Biotherapeutics, Inc., which was founded in 2015.
Postes actifs de Rachel Diamant
Sociétés | Poste | Début |
---|---|---|
Emendo Biotherapeutics, Inc.
![]() Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Fondateur | 01/01/2015 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Emendo Biotherapeutics, Inc.
![]() Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Health Technology |